Abscess of tendon sheath

M13_ABSCTENDON

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 M65.0
  • Cause of death: ICD-10 M65.0

2 out of 7 registries used, show all original rules.

215

4. Check minimum number of events

None

215

5. Include endpoints

None

215

6. Filter based on genotype QC (FinnGen only)

215

Control definitions (FinnGen only)

Control exclude
M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M65
Name in latin
Abscessus vaginae tendinis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1425 675 749
Only index persons 1365 650 715
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.02
Only index persons 0.03 0.02 0.03
Median age at first event (years)
Whole population 48.93 51.37 46.74
Only index persons 48.50 51.08 46.16

-FinnGen-

Key figures

All Female Male
Number of individuals 215 126 89
Unadjusted period prevalence (%) 0.04 0.04 0.04
Median age at first event (years) 52.12 48.87 56.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
188
Matched controls
1879
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M65.0
ICD-10 Finland
Abscess of tendon sheath
+∞
272.0
188
*
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
+∞
50.3
46
*
NDS00
NOMESCO Finland
Incision and debridement of infection of tendon of wrist or hand
+∞
42.3
39
*
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
30.9
22.1
29
11
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
86.5
21.2
23
*
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
26.0
19.7
27
12
WX204
NOMESCO Finland
Axillary plexus blockaced
21.7
19.3
28
15
M65.3
ICD-10 Finland
Trigger finger
30.2
18.3
24
9
M75.1
ICD-10 Finland
Rotator cuff syndrome
5.4
16.3
54
130
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
17.8
16.2
25
16
G56.0
ICD-10 Finland
Carpal tunnel syndrome
6.9
16.1
42
75
N03AX16
ATC
pregabalin; oral
4.6
15.9
64
190
ACC51
NOMESCO Finland
Release of median nerve
9.7
15.5
32
39
WX203
NOMESCO Finland
Infraclavicular plexus blockade
18.0
13.8
21
13
M79.6
ICD-10 Finland
Pain in limb
3.7
13.7
72
267
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
6.7
13.4
35
62
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
43.4
13.4
16
*
ZXD05
NOMESCO Finland
Urgent procedure
3.5
12.9
77
312
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
12.1
102
522
ZXA00
NOMESCO Finland
Right side
3.4
11.9
69
271
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
14.9
11.7
19
14
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
9.0
11.5
24
30
J01FF01
ATC
clindamycin; systemic
3.3
11.4
70
286
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
26.9
11.3
15
6
N02AX02
ATC
tramadol; systemic, rectal
3.0
11.2
90
442
S18
ICPC
Laceration/cut
2.9
11.0
94
479
ZXD20
NOMESCO Finland
Day surgery
4.6
10.5
38
98
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
116.1
10.5
11
*
NBG10
NOMESCO Finland
Acromioplastia
+∞
10.5
10
*
L03.0
ICD-10 Finland
Cellulitis of finger and toe
6.3
10.5
28
51
R4120
NOMESCO Finland
Occupational therapy
6.3
10.5
28
51
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
25.0
10.4
14
6
M01AH05
ATC
etoricoxib; oral
2.8
10.3
119
718
J01DB01
ATC
cefalexin; oral
3.7
9.8
166
1261
X59
ICD-10 Finland
Exposure to unspecified factor
3.4
9.4
50
179
N03AX12
ATC
gabapentin; oral
4.1
9.4
38
109
ZXE00
NOMESCO Finland
One hour or less
2.7
9.4
88
461
M01AE02
ATC
naproxen; oral, rectal
2.6
9.3
117
724
Z3226
NOMESCO Finland
Physiotherapist
3.5
9.1
48
169
M79.7
ICD-10 Finland
Fibromyalgia
17.3
8.7
13
8
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.3
8.6
26
55
M65.1
ICD-10 Finland
Other infective (teno)synovitis
+∞
8.4
8
*
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
15.4
8.3
13
9
N02AJ06
ATC
codeine and paracetamol; systemic
2.6
8.1
74
373
A46
ICD-10 Finland
Erysipelas
3.7
8.0
36
113
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.6
8.0
37
119
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.4
7.8
104
637
N06AX21
ATC
duloxetine; oral
4.4
7.8
28
72
N02BE01
ATC
paracetamol; systemic, rectal
3.2
7.8
165
1303
R4110
NOMESCO Finland
Physiotherapy
2.6
7.3
60
285
M79.0
ICD-10 Finland
Rheumatism, unspecified
31.3
7.2
9
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
9.3
7.2
14
16
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.0
7.2
22
48
M01AE03
ATC
ketoprofen; systemic, rectal
2.4
7.2
76
411
M48.0
ICD-10 Finland
Spinal stenosis
4.0
7.1
28
79
A02BC02
ATC
pantoprazole; systemic
2.3
7.0
126
874
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
7.0
77
424
ZXA05
NOMESCO Finland
Left side
2.7
7.0
53
237
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.4
6.9
24
60
X58
ICD-10 Finland
Exposure to other specified factors
3.4
6.8
34
116
NDQ20
NOMESCO Finland
Amputation of finger
41.6
6.8
8
*
M01AB05
ATC
diclofenac; systemic, rectal
2.3
6.8
126
884
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.2
6.8
20
42
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
23.5
6.7
9
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
23.5
6.7
9
*
M03BX02
ATC
tizanidine; oral
2.3
6.7
121
835
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
10.6
6.6
12
12
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
10.6
6.6
12
12
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
5.3
6.6
19
39
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
7.0
6.5
15
23
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
72.1
6.5
7
*
NDL52
NOMESCO Finland
Tenosynovectomy of hand
72.1
6.5
7
*
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
72.1
6.5
7
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.6
6.4
13
16
L12
ICPC
Hand/finger symptom/complaint
3.3
6.3
31
105
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.1
6.3
16
28
ND2AE
NOMESCO Finland
Hand and fingers ultrasound examination
+∞
6.3
6
*
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
+∞
6.3
6
*
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
27.7
6.3
8
*
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
27.7
6.3
8
*
M10.9
ICD-10 Finland
Gout, unspecified
4.7
6.3
20
46
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
8.1
6.2
13
17
M77.1
ICD-10 Finland
Lateral epicondylitis
4.9
6.2
19
42
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
9.1
6.1
12
14
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
9.1
6.1
12
14
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.1
6.1
23
62
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
10.5
6.1
11
11
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
10.5
6.1
11
11
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
6.0
27
85

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
90
218
6.38
38.31
2.7
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
21
11.56
20.34
1.6
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
100
409
3.70
19.71
6.2
3.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
88
378
3.25
15.32
3.5
2.7
umol/l
336.8
9836.3
2.41
82
326
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
36
7.03
14.41
2.3
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
13
11.45
12.99
1.4
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
50
179
3.34
11.40
2.7
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
51
191
3.19
10.76
1.5
1.3
titre
280.0
462.4
—
8
34
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
261
2.80
9.62
1.3
1.2
iu/ml
15.1
28.6
1.13
16
77
(3001604) Monocytes [#/volume] in Blood
127
813
2.37
8.70
8.5
5.7
e9/l
0.6
0.6
0.79
114
705
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
123
780
2.35
8.57
9.2
6.6
mmol/l
1.2
1.2
0.02
107
671
(3006315) Basophils [#/volume] in Blood
127
818
2.35
8.51
8.5
5.7
e9/l
0.0
0.0
0.14
114
708
(3019198) Lymphocytes [#/volume] in Blood
128
833
2.33
8.30
8.5
5.6
e9/l
2.7
2.1
0.43
118
739
(3044640) Blood type and Crossmatch panel - Blood
91
516
2.32
8.14
2.4
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
120
767
2.28
8.03
4.6
3.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
107
657
2.25
7.84
2.4
2.1
nmol/l
79.5
76.9
0.31
99
592
(3013707) Erythrocyte sedimentation rate by Westergren method
166
1229
2.54
7.73
5.3
3.6
mm/h
13.5
11.3
1.21
159
1128
(3021788) Differential panel - Synovial fluid
11
15
7.67
7.62
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
84
3.53
7.54
1.3
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
127
845
2.23
7.53
8.7
5.9
e9/l
0.2
0.2
0.30
116
749
(42870588) Differential panel, method unspecified - Blood
89
519
2.22
7.27
8.4
5.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
139
969
2.23
7.21
5.7
4.7
mmol/l
7.2
6.7
1.32
132
902
(3021589) Normoblasts [#/volume] in Blood
116
760
2.14
6.97
16.4
9.1
e9/l
0.0
0.0
0.69
104
632
(3007164) IgA [Mass/volume] in Serum or Plasma
66
345
2.32
6.96
1.5
1.4
g/l
2.6
2.6
0.04
43
213
(3032080) INR in Blood by Coagulation assay
101
630
2.14
6.86
13.3
7.7
inr
1.1
1.2
1.02
37
195
(3006504) Eosinophils/100 leukocytes in Blood
117
772
2.13
6.86
9.0
5.6
%
2.6
2.8
0.42
112
727
(3022096) Basophils/100 leukocytes in Blood
113
740
2.11
6.72
9.1
5.7
%
0.6
0.7
0.59
107
696
(3002030) Lymphocytes/100 leukocytes in Blood
119
796
2.11
6.67
9.1
5.7
%
28.2
28.6
0.10
114
750
(40767503) Oxygen content in Capillary blood by calculation
12
21
5.99
6.66
2.5
3.0
%
16.5
16.2
—
7
14
(3019069) Monocytes/100 leukocytes in Blood
117
778
2.11
6.66
9.2
5.9
%
8.0
8.6
1.42
112
737
(3018095) Leukocytes [#/volume] in Urine
93
569
2.12
6.58
3.7
3.1
e6/l
74.3
65.5
0.05
67
393
(3013650) Neutrophils [#/volume] in Blood by Automated count
137
975
2.12
6.41
10.0
9.5
e9/l
4.5
4.1
1.16
127
857
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
84
500
2.12
6.34
3.1
2.1
u/l
63.0
57.6
0.30
79
461
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
160
2.67
6.32
5.4
3.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
82
485
2.12
6.28
6.0
3.9
ph
7.4
7.4
0.79
20
92
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
69
385
2.17
6.12
2.4
2.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
44
203
2.47
6.07
4.5
2.1
%
22.8
24.0
0.26
37
177
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
123
852
2.04
6.06
6.2
6.8
umol/l
10.6
10.8
0.09
117
819
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
50
245
2.36
6.04
1.4
1.2
u/ml
15.2
7.6
0.26
20
88
(40758558) Short blood count panel - Blood
71
405
2.12
5.92
6.9
7.4
—
—
—
0
0
(3044889) 12 lead EKG panel
157
1196
2.16
5.89
4.6
3.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
166
1304
2.20
5.58
10.7
7.4
u/l
81.0
75.8
0.68
160
1222
(3000494) Fungus identified in Specimen by Culture
42
200
2.37
5.38
1.5
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
79
484
2.00
5.35
4.1
3.0
mmol/l
7.0
7.9
1.12
66
397
(36304419) Bacteria [Presence] in Urine
72
427
2.03
5.34
3.0
2.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
87
556
1.95
5.19
3.6
2.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
36
163
2.45
5.14
1.9
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
73
441
1.99
5.11
3.2
2.7
e6/l
0.3
0.5
0.61
58
320
(3021879) Hepatitis B virus core Ab [Presence] in Serum
31
131
2.60
5.10
1.3
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
36
164
2.44
5.07
1.9
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
73
443
1.98
5.03
4.0
3.2
mg/l
830.0
364.4
0.25
54
278
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
192
2.33
5.02
2.1
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
47
242
2.21
5.00
1.8
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
117
833
1.89
4.96
3.9
3.2
estimate
0.0
0.0
0.00
28
147
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
28
4.48
4.89
1.5
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
199
1724
3.07
4.86
25.7
12.2
mg/l
25.4
24.0
0.27
182
1338
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
109
2.69
4.85
1.8
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
51
276
2.11
4.78
2.1
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
29
123
2.57
4.73
9.5
8.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
49
263
2.12
4.68
2.7
2.5
e6/l
1.1
1.3
0.10
29
141
(3033658) Prothrombin time (PT) actual/Normal
67
405
1.95
4.62
6.2
3.3
%
92.2
93.1
0.09
67
396
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
76
2.95
4.60
5.6
8.1
mmol/l
24.1
25.1
0.75
21
76
(3002582) Erythrocytes [#/volume] in Urine
76
480
1.90
4.59
3.2
2.7
e6/l
25.7
61.4
1.50
60
358
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
91
610
1.85
4.56
2.3
1.8
pmol/l
93.0
95.4
0.20
49
305
(3035350) Ketones [Presence] in Urine by Test strip
114
820
1.83
4.54
3.9
3.2
estimate
0.0
0.0
0.00
31
157
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
57
328
2.00
4.51
2.0
1.6
mg/l
0.9
1.2
1.20
44
255
(3020682) Albumin/Creatinine [Ratio] in Urine
75
475
1.89
4.47
5.0
3.9
mg/mmol
12.8
9.0
0.24
57
291
(3037467) Urinalysis macro (dipstick) panel - Urine
146
1147
1.85
4.23
4.7
3.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
24
98
2.63
4.22
1.3
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
113
824
1.78
4.19
5.3
4.5
estimate
0.0
0.0
0.00
32
159
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
60
362
1.91
4.10
3.0
1.9
mg/l
2.7
3.0
0.63
55
311
(3001122) Ferritin [Mass/volume] in Serum or Plasma
103
736
1.77
4.05
4.4
2.5
ug/l
151.7
130.4
0.40
90
677
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
44
239
2.06
4.05
2.9
2.6
e6/l
1.5
2.4
0.61
24
119
(3021960) Folate [Moles/volume] in Serum or Plasma
57
344
1.89
3.88
1.7
1.4
nmol/l
20.7
20.4
0.04
50
293
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
44
3.33
3.85
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
44
3.33
3.85
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
44
3.33
3.85
1.3
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
62
388
1.84
3.76
5.8
4.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
26
3.98
3.56
4.5
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
54
330
1.85
3.51
2.2
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
191
1681
2.22
3.46
20.9
11.1
ml/min/173m2
81.2
83.0
0.40
154
1355
(3018677) aPTT in Platelet poor plasma by Coagulation assay
41
230
1.97
3.43
2.6
1.8
s
31.4
29.2
1.39
41
222
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
42
3.23
3.43
2.4
2.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
83
2.55
3.42
1.5
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
21
90
2.48
3.37
10.0
10.3
%
94.7
94.6
0.05
21
90
(3023520) Reticulocytes [#/volume] in Blood
25
117
2.29
3.32
2.9
2.9
e9/l
70.4
70.1
0.02
17
94
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
57
360
1.79
3.32
1.4
1.2
u/ml
4.3
1.7
0.30
14
93
(40761511) CBC panel - Blood by Automated count
203
1847
2.78
3.17
20.5
11.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
26
127
2.19
3.12
6.3
4.1
mmol/l
1.2
1.2
0.54
26
114
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
139
1128
1.66
3.08
2.9
3.2
—
—
—
0
0
(3012544) pH of Venous blood
29
149
2.09
3.08
4.7
3.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
34
186
1.98
3.05
2.9
2.3
ug/g
296.4
133.6
0.52
28
143
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
156
1307
1.71
3.04
5.0
3.6
pmol/l
14.1
14.7
2.79
149
1183
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
24
115
2.22
3.02
6.3
2.9
ng/l
150.7
75.1
1.69
19
104
(3002179) Metamyelocytes/100 leukocytes in Blood
25
122
2.19
3.01
3.9
4.2
%
0.5
0.5
—
6
33
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
50
312
1.79
3.01
1.8
1.7
pmol/l
435.8
426.7
0.09
44
274
(3015377) Calcium [Moles/volume] in Serum or Plasma
75
525
1.66
2.98
2.4
3.4
mmol/l
2.3
2.4
0.27
67
469
(3022806) Fractional oxyhemoglobin in Capillary blood
6
9
6.82
2.88
2.5
2.4
%
88.9
89.9
—
6
9
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
53
2.76
2.85
1.1
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
359
1.71
2.82
4.0
3.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
31
3.33
2.81
1.2
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
24
119
2.14
2.79
4.1
4.4
%
0.0
0.1
—
7
37
(3020564) Creatinine [Moles/volume] in Serum or Plasma
205
1892
2.80
2.76
24.8
14.2
umol/l
83.9
75.7
1.35
205
1892
(3003694) ABO and Rh group [Type] in Blood
70
490
1.64
2.75
1.6
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
7
14
5.13
2.75
2.3
2.4
mmol/l
1.3
1.5
—
7
14
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
288
1.76
2.73
5.5
3.5
ng/l
55.0
320.6
1.66
34
226
(3019309) Folate [Moles/volume] in Red Blood Cells
42
256
1.80
2.72
1.7
1.6
nmol/l
1395.7
1195.7
0.45
32
190
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
49
313
1.73
2.71
1.8
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
27
142
2.03
2.70
3.7
3.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
15
4.78
2.62
1.3
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
35
204
1.85
2.61
1.3
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
7
7.28
2.56
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
143
1197
1.58
2.55
3.9
2.8
u/l
51.4
45.8
0.38
132
1135
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
45
2.77
2.49
1.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
83
2.28
2.49
1.4
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
31
178
1.87
2.43
3.6
2.8
umol/l
5.9
8.3
0.84
22
159
(3021440) Promyelocytes/100 leukocytes in Blood
24
126
2.02
2.42
4.1
4.4
%
0.0
0.1
—
7
42
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
40
2.84
2.41
1.7
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
87
659
1.54
2.39
2.0
2.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
61
427
1.60
2.36
3.5
3.3
ng/l
2761.3
1094.5
0.70
54
363
(40760888) Immunoglobulin light chains.free panel - Serum
10
35
2.95
2.33
1.0
4.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
8
23
3.57
2.29
5.6
2.8
kpa
5.0
4.9
—
8
23
(40768443) Skin Pathology biopsy report
14
60
2.43
2.27
1.5
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
29
3.19
2.25
2.0
2.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
29
3.19
2.25
3.8
2.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
29
3.19
2.25
1.6
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
29
3.19
2.25
1.6
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
12
48
2.59
2.22
3.8
2.2
ug/l
148.3
216.1
0.64
12
48
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
61
2.39
2.19
1.2
1.4
miu/ml
115.0
239.7
—
6
32
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
196
1803
1.99
2.19
5.5
4.5
mmol/l
2.7
2.8
0.60
188
1672
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
194
1780
1.92
2.16
4.8
4.1
mmol/l
4.7
4.7
0.01
184
1670
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
30
177
1.81
2.16
8.9
7.9
kpa
5.2
5.1
0.10
30
171
(3027801) Oxygen [Partial pressure] in Arterial blood
30
177
1.81
2.16
8.9
7.9
kpa
11.3
12.6
0.83
30
172
(3017181) Myelocytes/100 leukocytes in Blood
25
139
1.90
2.16
4.1
4.2
%
1.0
0.9
—
7
49
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
204
1907
2.36
2.13
14.6
9.5
u/l
26.9
26.2
0.24
199
1838
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
62
2.35
2.12
1.6
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
25
3.28
2.11
3.4
2.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
61
438
1.55
2.10
4.3
3.3
estimate
0.0
0.0
0.50
30
152
(3023419) Bacteria identified in Sputum by Culture
7
20
3.58
2.07
5.6
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
12
50
2.48
2.06
2.5
1.9
u/l
44.5
1889.4
—
5
15
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
178
1601
1.65
2.05
6.2
4.3
mu/l
1.9
1.9
0.28
167
1457
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
15
70
2.23
2.03
1.9
2.6
u/l
36.7
38.0
0.08
15
64
(3005322) IgE [Units/volume] in Serum or Plasma
17
85
2.09
1.96
1.5
1.2
u/ml
204.8
136.9
0.39
17
75
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
192
1771
1.79
1.89
4.6
4.1
mmol/l
1.5
1.5
0.03
181
1647
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
25
147
1.79
1.83
3.0
2.1
u/l
53.6
30.3
0.39
19
131
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
42
285
1.59
1.83
2.8
2.8
mmol/l
2.5
2.4
0.14
37
257
(3027315) Oxygen [Partial pressure] in Blood
7
23
3.11
1.81
6.3
2.8
kpa
8.6
9.1
—
7
23
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
88
2.01
1.80
1.1
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
61
453
1.48
1.77
3.3
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
181
1.70
1.75
1.2
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
48
2.36
1.73
2.9
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
84
670
1.42
1.66
4.0
3.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
13
63
2.13
1.63
1.1
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
14
3.63
1.62
1.2
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
32
2.56
1.61
3.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
32
2.56
1.61
1.5
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
50
2.26
1.60
1.5
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
26
2.75
1.59
1.3
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
86
1.93
1.55
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
75
593
1.41
1.54
5.6
3.5
ng/l
29.0
34.8
0.34
60
399
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
95
1.86
1.48
1.1
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
179
1648
1.51
1.47
25.5
12.8
%
39.6
40.2
0.53
135
1234
(3022145) Colonoscopy Study observation
27
174
1.63
1.46
1.3
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
16
3.17
1.44
2.0
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
6
23
2.65
1.37
1.0
1.0
g/l
1.6
1.5
—
6
18
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
17
2.99
1.36
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
54
2.09
1.35
3.5
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
130
1.68
1.32
2.2
2.6
ml/min/173m2
54.2
63.2
0.52
13
56
(3035637) Corticotropin [Mass/volume] in Plasma
5
18
2.82
1.29
1.8
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
62
488
1.38
1.29
3.4
2.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
36
2.27
1.25
1.3
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
37
2.21
1.23
1.0
1.2
—
11.7
—
0
10
(3019230) Fractional oxyhemoglobin in Venous blood
5
19
2.67
1.22
3.0
1.6
%
58.2
60.7
—
5
19
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
19
2.67
1.22
1.0
1.2
mmol/l
5.7
3.9
—
5
19
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
184
1721
1.48
1.21
4.3
3.7
mmol/l
1.4
1.3
2.07
171
1597
(1002224) Polysomnography panel
14
79
1.83
1.20
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
26
2.34
1.19
2.8
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
20
2.53
1.15
3.6
3.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
20
2.53
1.15
1.0
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
58
1.94
1.14
1.7
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
28
194
1.51
1.14
2.1
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
21
2.41
1.09
3.0
2.8
%
62.2
55.0
—
5
21
(3016879) Cocaine [Presence] in Urine
11
59
1.91
1.09
3.5
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
60
1.88
1.05
3.6
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
60
1.88
1.05
3.5
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
60
1.88
1.05
3.5
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
68
1.81
1.02
3.2
2.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
61
1.85
1.00
3.6
1.7
—
—
—
0
0
(4010399)
18
116
1.60
1.00
1.9
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
23
2.20
0.98
2.0
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
54
1.89
0.98
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
23
159
1.50
0.96
1.3
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
20
135
1.53
0.93
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
28
2.17
0.92
2.5
2.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
13
79
1.69
0.90
3.6
2.3
%
0.6
0.7
0.79
13
79
(3020891) Body temperature
10
56
1.82
0.89
3.6
3.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
179
1.45
0.89
2.2
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
43
1.89
0.88
5.0
2.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
45
1.81
0.85
3.6
2.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
31
1.96
0.85
3.7
9.0
—
142.9
—
0
7
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
31
1.96
0.85
2.3
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
26
190
1.42
0.84
1.9
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
29
218
1.38
0.80
1.2
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
82
1.62
0.80
3.6
2.3
%
1.1
1.2
0.20
13
82
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
180
1708
1.33
0.79
5.1
4.1
mmol/l
6.2
5.9
1.29
170
1563
(1617658) Protocol used for examination of sentinel lymph nodes
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
165
1549
1.28
0.78
30.1
15.2
g/l
331.2
332.8
1.75
165
1542
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
195
1.38
0.74
2.4
2.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
60
1.70
0.73
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.6
1.7
—
—
—
0
0
(4034850)
9
57
1.60
0.72
17.7
7.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
2.0
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
30
1.68
0.62
1.6
2.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
20
0.00
0.60
0.0
2.1
—
—
—
0
0
(3013512) EKG study
54
464
1.22
0.57
5.9
3.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
90
1.47
0.57
2.2
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
54
466
1.21
0.55
1.7
1.6
mmol/l
1.4
1.4
0.21
48
392
(3037756) Immunofixation for Serum or Plasma
6
39
1.55
0.53
1.0
1.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
14
100
1.43
0.53
5.1
6.8
mmol/l
26.5
24.8
2.06
14
94
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
83
1.47
0.53
13.4
10.5
—
—
—
0
0
(3009343) pH of Capillary blood
13
96
1.38
0.42
3.5
3.5
ph
7.4
7.4
—
7
12
(3022621) pH of Urine by Test strip
13
96
1.38
0.42
2.8
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.58
0.42
2.0
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
58
1.39
0.42
2.4
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
16
0.00
0.41
0.0
2.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
17
0.00
0.41
0.0
2.4
—
12.9
—
0
17
(3004616) Nuclear Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
35
1.44
0.39
1.8
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
2.5
—
74.7
—
0
19
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.8
—
2.7
—
0
19
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
180
1.25
0.37
1.6
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
37
1.36
0.37
1.4
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
76
0.65
0.36
5.6
3.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
41
1.48
0.36
3.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
82
1.36
0.35
4.3
4.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.8
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.8
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
54
1.31
0.30
1.9
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
56
512
1.13
0.29
4.5
4.8
ug/l
1.3
2.8
1.66
48
457
(3050129) First trimester maternal screen panel - Serum or Plasma
8
63
1.28
0.28
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
33
293
1.15
0.26
2.4
3.1
ug/l
0.5
0.8
2.90
16
183
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
114
1.24
0.26
2.1
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
105
1.25
0.25
1.5
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
305
1.14
0.23
1.3
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
126
1.20
0.21
4.1
3.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
10.6
—
889.7
—
0
11
(3000012) Reticulocyte production index
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(44813793)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
13.6
—
1671.0
—
0
11
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
4.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
21
184
1.16
0.20
9.2
6.5
—
—
—
0
0
(3019225) pH of Specimen
16
137
1.18
0.19
4.6
4.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
52
1.16
0.19
1.5
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
53
1.14
0.19
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
236
0.88
0.17
1.1
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
102
1.19
0.15
2.8
4.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
18
201
0.89
0.14
4.8
4.0
%
32.1
31.7
0.05
12
131
(4094501)
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
44
1.14
0.10
1.2
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
47
1.07
0.09
1.4
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
69
713
0.95
0.09
3.1
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
57
1.05
0.08
1.2
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
5
60
0.83
0.08
1.2
1.4
nmol/l
45.4
41.4
—
5
60
(4035726)
14
154
0.90
0.08
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
68
1.03
0.08
1.1
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
41
401
1.03
0.02
4.0
4.3
%
23.3
20.8
0.35
13
180
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
126
1.03
0.00
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
19
185
1.03
0.00
3.2
4.6
ug/l
1.9
7.9
1.78
12
153
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
54
0.92
0.00
2.4
1.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.0
—
4.0
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
3.2
—
24.3
—
0
5
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
110.2
—
0
6
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
59
1.02
0.00
1.3
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
8.3
—
0
7
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
23.2
—
0
6
(3013727) Leukocytes other/100 leukocytes in Blood
0
7
0.00
0.00
0.0
5.7
—
38.3
—
0
7
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
85
0.94
0.00
2.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
16.5
—
0
8
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
64
0.94
0.00
1.3
2.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.7
—
4.8
—
0
7
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
51
0.98
0.00
3.8
5.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint M13_ABSCTENDON and mortality.

Females

Parameter HR [95% CI] p-value
M13_ABSCTENDON 1.179 [0.9, 1.55] 0.235
Birth year 0.999 [0.99, 1.01] 0.723

During the follow-up period (1.1.1998 — 31.12.2019), 76 out of 589 females with M13_ABSCTENDON died.

Males

Parameter HR [95% CI] p-value
M13_ABSCTENDON 1.623 [1.22, 2.17] 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 82 out of 624 males with M13_ABSCTENDON died.

Mortality risk

Mortality risk for people of age

years, who have M13_ABSCTENDON.

N-year risk Females Males
1 0.108% 0.294%
5 0.704% 1.659%
10 1.838% 4.204%
15 3.309% 8.465%
20 6.222% 14.247%

Relationships between endpoints

Index endpoint: M13_ABSCTENDON – Abscess of tendon sheath

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data